Glycosaminoglycans

Japan’s Kewpie Corporation, Pioneer of the Hyaluronic Acid Revolution, Has Just Revealed Its Mechanism

Retrieved on: 
Wednesday, July 28, 2021

Now Kewpie Corporation has forged new ground by releasing heretofore unknown evidence of how that works.

Key Points: 
  • Now Kewpie Corporation has forged new ground by releasing heretofore unknown evidence of how that works.
  • In June of this year Kewpie addressed that same ISHAS conference, and it once again changed the game.
  • As hyaluronan activates the collagenic cycle beneath the corneal layer of the skin, its loss disrupts the skins ability to maintain moisture.
  • This responsibility is central to Kewpie Corporations credo, and it makes Hyabest(S)LF-P, its producer and culture singular in the field.

Global Artificial Tears Market Forecast (2020 to 2028) - COVID-19 Impact and Analysis - ResearchAndMarkets.com

Retrieved on: 
Friday, July 9, 2021

The "Artificial Tears Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type, Delivery Mode, and Application" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Artificial Tears Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type, Delivery Mode, and Application" report has been added to ResearchAndMarkets.com's offering.
  • However, the poor accessibility to eye care services in low-income countries hinders the growth of the artificial tears market.
  • The global artificial tears market is segmented on the bases of type, delivery mode, and application.
  • Based on type, the market is segmented into cellulose derived tears, glycerin derived tears, oil-based emulsion tears, polythylene glycol-based tears, propylene glycol-based tears, and sodium hyaluronate based artificial tears.

Qilian International Holding Group Limited Enters into Investment Agreement for Pig By-product Processing Project in Chongqing

Retrieved on: 
Friday, July 9, 2021

The Project is expected to receive preferential policies from the government at the national, municipal and local levels.

Key Points: 
  • The Project is expected to receive preferential policies from the government at the national, municipal and local levels.
  • Mr. Zhanchang Xin, Chairman and CEO of the Company, commented, We are very pleased to work with CJT on the Project.
  • As a key area for pig breeding and pork production in China, Chongqing has sufficient raw materials for the production of heparin sodium preparations.
  • Qilian International Holding Group Limited, headquartered in Gansu, China, is a pharmaceutical and chemical products manufacturer in China.

Galderma Receives FDA Approval for Restylane® Contour for Cheek Augmentation and Correction of Midface Contour Deficiencies

Retrieved on: 
Tuesday, June 29, 2021

Results showed that Restylane Contour is safe and effective for cheek augmentation and the correction of midface contour deficiencies.

Key Points: 
  • Results showed that Restylane Contour is safe and effective for cheek augmentation and the correction of midface contour deficiencies.
  • Most patients* (85%) did not experience any adverse events (AEs) related to treatment with Restylane Contour.
  • The Restylane family of products are indicated for patients over the age of 21, and includes Restylane, Restylane-L, RestylaneLyft with Lidocaine, Restylane Silk, Restylane Kysse, Restylane Refyne, Restylane Defyne, and Restylane Contour.
  • Restylane Contour is for cheek augmentation and for the correction of midface contour deficiencies.

MYOS CORP to Attend VMX In Person, Will Introduce Three Products, Two Clinical Studies, and Vet Advisory Board

Retrieved on: 
Tuesday, June 1, 2021

The Company will provide industry leaders with updates on three new products within its MYOS Pet line of pet supplements, two new successful clinical studies and the recent formation of MYOS' Veterinary Advisory Board.

Key Points: 
  • The Company will provide industry leaders with updates on three new products within its MYOS Pet line of pet supplements, two new successful clinical studies and the recent formation of MYOS' Veterinary Advisory Board.
  • "Our team is very excited to be returning in person for another terrific VMX show," said MYOS CEO Joe Mannello.
  • MYOS Canine Muscle Formula with Green Lipped Mussel: This new product will feature a blend of Fortetropin and Green Lipped Mussel.
  • GLM is a rich source of glycosaminoglycans (GAGs) such as chondroitin sulfate that are a necessary component for cartilage repair.

Croma-Pharma Presents New Cosmetic Skincare Brand "Croma farewell™" For Common Skin Conditions

Retrieved on: 
Monday, May 31, 2021
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210531005179/en/
    The Austrian produced brand will initially launch in all key markets with facial serums for five specific skin types.
  • Genetics, external factors and psychological influences can have a decisive impact on an individuals skin condition and lead to various problems.
  • farewell irritated skin: Target-specific face serum for irritated, sensitive skin with Hyaluronic Acid, Madecassoside, Niacinamide and D-Panthenol to sooth irritations, reduce skin redness and strengthen the skin barrier.
  • farewell dry skin: farewell dry skin contains hydrating ingredients including Hyaluronic Acid, Niacinamide, D-Panthenol and Aloe Vera to effectively nourish the skin and strengthen the skin barrier.

As an Ode to Joints on National Jogging Day (June 2); Purity Products® Promotes Game-Changing Joint Care Supplement

Retrieved on: 
Wednesday, May 26, 2021

PLAINVIEW, N.Y., May 26, 2021 /PRNewswire/ --In celebration of National Jogging Day on June 2, Purity Products is highlighting their best-selling FLEXURON supplement for mitigating the wear and tear on joints.

Key Points: 
  • PLAINVIEW, N.Y., May 26, 2021 /PRNewswire/ --In celebration of National Jogging Day on June 2, Purity Products is highlighting their best-selling FLEXURON supplement for mitigating the wear and tear on joints.
  • In a finished product clinical study, FLEXURON delivered 3X better benefits for maximizing joint comfort, on average, than glucosamine and chondroitin.
  • "However, the constant force versus walking creates more weighted impact to the knees and other joints, which may result in pain.
  • With over 200 cutting-edge formulations serving well over one million customers, Purity Products stands at the intersection of science and innovation.

Outlook on the Hyaluronic Acid Global Market to 2025 - Featuring Anika Therapeutics, Allergan and Genzyme Among Others - ResearchAndMarkets.com

Retrieved on: 
Wednesday, April 28, 2021

b'The "Hyaluronic Acid Global Market Insights 2020, Analysis and Forecast to 2025, by Manufacturers, Regions, Technology, Application" report has been added to ResearchAndMarkets.com\'s offering.\nThis report describes the global market size of Hyaluronic Acid from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026.\nFor the geography segment, regional supply, demand, major players, price is presented from 2016 to 2026.

Key Points: 
  • b'The "Hyaluronic Acid Global Market Insights 2020, Analysis and Forecast to 2025, by Manufacturers, Regions, Technology, Application" report has been added to ResearchAndMarkets.com\'s offering.\nThis report describes the global market size of Hyaluronic Acid from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026.\nFor the geography segment, regional supply, demand, major players, price is presented from 2016 to 2026.
  • This report covers the following regions:\n'

United States Orthobiologics Market Report 2021: Bone Graft Substitutes, Cellular Allografts, Orthopedic Cell Therapy, Hyaluronic Acid Viscosupplementation & Orthopedic Cartilage Repair Devices - ResearchAndMarkets.com

Retrieved on: 
Monday, April 26, 2021

b'The "U.S. Orthobiologics Market Analysis - COVID19 - 2019-2025 - MedSuite - Includes: Bone Graft Substitutes, Cellular Allografts, Growth Factors, Orthopedic Cell Therapy, Hyaluronic Acid Viscosupplementation & Orthopedic Cartilage Repair Devices" report has been added to ResearchAndMarkets.com\'s offering.\nU.S.

Key Points: 
  • b'The "U.S. Orthobiologics Market Analysis - COVID19 - 2019-2025 - MedSuite - Includes: Bone Graft Substitutes, Cellular Allografts, Growth Factors, Orthopedic Cell Therapy, Hyaluronic Acid Viscosupplementation & Orthopedic Cartilage Repair Devices" report has been added to ResearchAndMarkets.com\'s offering.\nU.S.
  • orthopedic biomaterials market was valued at $3.1 billion in 2020.
  • The goal is to penetrate the high-growth segments and build or strengthen networks before the segment matures.
  • This is especially the case for competitors in segments that are in decline, such as competitors in the five-injection hyaluronic acid treatment.\nMedtronic leads the U.S. orthopedic biomaterials market.

HTL Biotechnology and Echelon Biosciences Inc. announce strategic partnership to advance biopolymer platform and hyaluronic acid research tools

Retrieved on: 
Wednesday, April 14, 2021

The partnership will enable distribution of high-quality HA and glycosaminoglycan (GAG), and the co-development of novel GAG products.\nThis press release features multimedia.

Key Points: 
  • The partnership will enable distribution of high-quality HA and glycosaminoglycan (GAG), and the co-development of novel GAG products.\nThis press release features multimedia.
  • HTL, the worldwide leader in biotechnology solutions using hyaluronic acid (HA) and other biopolymers, and Echelon Biosciences Inc., a U.S.-based global supplier of biochemical reagents, assays, and services to research and development laboratories, announced today their new distribution and product development partnership.
  • https://htlbiotech.com/\nThe partnership provides academic research and pharmaceutical development laboratories\xe2\x80\x99 expanded access to Good Manufacturing Practices (GMP)-grade, kit-packaged hyaluronic acid and glycosaminoglycan (GAG) products.
  • HTL is recognized internationally for producing biopolymers of premium quality,\xe2\x80\x9d says Bert Israelsen , president of Echelon Biosciences .